Why haven’t microbial products been more widely adopted by farmers?
Posted 14th October 2020 by Joshua Sewell
This is a question that drives me each day. Microbial products have been around for a long time; starting with rhizobium in legumes, dating back 125 years. Yet, in the United States, rhizobium inoculants have not been widely adopted by soybean farmers – some indicate less than 15% use overall in the United States. Why?
Deep Neural Networks in image processing, predictive modelling and diagnostic decisions
Posted 2nd September 2020 by Liv Sewell
Now more than ever intelligent human beings are needed to fulfil high value and high complexity tasks and histopathology is no exception. In fact, it is one of the sectors in the most desperate need.
Multiplex and high fidelity: the potential of qPCR
Posted 28th August 2020 by Joshua Sewell
Ahead of the qPCR & Digital PCR Congress, we sat down with David Zhang to talk about his work with PCR as a diagnostic platform.
From Consortia to Recombinants: opportunities and challenges facing the next generation of microbials
Posted 24th August 2020 by Liv Sewell
In this blog post I will discuss two themes that I see driving the next generation of live microbe biologicals for agriculture. These are the rational design and delivery of pairs or consortia (which I will define as more than two microbes) and the commercialization of engineered strains.
How deep learning is transforming medical imaging: image search
Posted 29th July 2020 by Liv Sewell
Five or six years ago, I was looking for a strategic direction for the KIMIA Lab. We started with the problems. We asked, ‘What problems do we have in medical imaging?’
Colorectal cancer discovery raises hope for microbiome treatment
Posted 22nd July 2020 by Joshua Sewell
This article is republished with kind permission from BioVox.
A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University.
What AI Can and Can’t Do for Digital Pathology Right Now
Posted 15th July 2020 by Liv Sewell
It was fascinating to speak with Hamid Tizhoosh, Professor at the Faculty of Engineering at the University of Waterloo in Canada, Director of KIMIA Lab and keynote speaker at the 6th Digital Pathology & AI Congress: USA, about using AI to transform what is possible in medical imaging.
How to translate biomarker discoveries into clinical applications
Posted 8th July 2020 by Joshua Sewell
Extracellular vesicles provide an exciting opportunity as a modality for non-invasive biomarkers, which may enable them to be used as biomarkers for tumour metastasis.